Moreover, in a 1-year follow-up assessment of blood biomarkers in patients who experienced stroke (64.5 ± 9.5 years), higher TNF-α and IL-1β levels were associated with poor outcomes at 1-year post-stroke [67]. The gene discussed is IL1B; the disease is stroke disorder.